Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”: [ESMO Open 9 (2024) 103703](S2059702924014728)(10.1016/j.esmoop.2024.103703)

Hofheinz RD, Herrle F, Dechow T, von Weikersthal LF, Welslau M, Lettmaier S, Burkart C, Kubicka S, Kochen L, Merx K, Krause K, Ebert M, Rödel C, Fokas E, Ghadimi M, Reissfelder C, Gaiser T (2025)

Publication Language: English

Publication Type: Journal article, Erratum

Publication year: 2025

Journal

ESMO Open BMJ Publishing Group

Book Volume: 10

Article Number: 104095

Journal Issue: 2

DOI: 10.1016/j.esmoop.2024.104095

Abstract

The authors regret that in the original publication of this article the full title was not given. The correct and full title is now given above. The authors would like to apologise for any inconvenience caused.

Involved external institutions

Universitätsklinikum Mannheim DE Germany (DE) Onkologie | Hämatologie Ravensburg DE Germany (DE) Klinikum St. Marien Amberg DE Germany (DE) Klinikum Aschaffenburg DE Germany (DE) Schwarzwald-Baar Klinikum DE Germany (DE) Kreiskliniken Reutlingen DE Germany (DE) Frankfurter Institut für Klinische Krebsforschung IKF GmbH / Frankfurt Institute of Clinical Cancer Research DE Germany (DE) AIO-Studien-gGmbH DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf (CIO ABCD) DE Germany (DE) Universitätsklinikum Göttingen DE Germany (DE) Institut für angewandte Pathologie DE Germany (DE)

How to cite

APA:

Hofheinz, R.D., Herrle, F., Dechow, T., von Weikersthal, L.F., Welslau, M., Lettmaier, S.,... Gaiser, T. (2025). Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”: [ESMO Open 9 (2024) 103703](S2059702924014728)(10.1016/j.esmoop.2024.103703). ESMO Open, 10(2). https://doi.org/10.1016/j.esmoop.2024.104095

MLA:

Hofheinz, R. D., et al. "Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”: [ESMO Open 9 (2024) 103703](S2059702924014728)(10.1016/j.esmoop.2024.103703)." ESMO Open 10.2 (2025).

BibTeX: Download